Recalls & Warnings July 06, 2022 FDA Warns Kratom Companies for Arthritis, Pain Relief Claims & More On January 30, 2022, the FDA issued warning letters to four sellers of kratom products because they were promoted to treat pain relief, opioid withdrawal, blood sugar control, anxiety, and to treat rheumatoid arthritis
reconstitute under sterile conditions
Your guidance was invaluable during all the steps, decisions, and options that needed to be discussed and decided
After one to two weeks of treatment, many patients report feeling mentally clearer and emotionally more balanced
Diabetologia 58 (4), 799808
These are not clinical arguments